Luxembourg Beate, Schmitt Joern, Humpich Marek, Glowatzki Matthias, Seifried Erhard, Lindhoff-Last Edelgard
Division of Vascular Medicine and Haemostaseology, University Hospital Frankfurt, 60590 Frankfurt, Germany.
Blood Coagul Fibrinolysis. 2009 Oct;20(7):524-34. doi: 10.1097/MBC.0b013e32832d9b58.
Elevated clotting factors have been demonstrated to be a risk factor for venous thromboembolism (VTE). The aim of our study was to investigate the impact of age, sex, body mass index, and oral contraceptives on the clotting factor activities of factors VIII, IX, XI, and XII and their impact on the cutoff definition and risk of VTE associated with elevated clotting factors. Factor VIII, IX, XI, and XII activities were measured in 499 blood donors and 286 patients with VTE. Age and body mass index predicted significantly and independently the clotting factor activities of factors VIII, IX, and XI, whereas use of oral contraceptives predicted factor IX, XI, and XII levels. Percentiles of clotting factor activities, which are often used for the cutoff definition of elevated clotting factors, varied due to the effect of age, body mass index, and oral contraceptives. The adjusted odds ratios for VTE were 10.3 [95% confidence interval (CI) 5.1-20.7], 6.1 (95% CI 3.1-12.0), and 3.3 (95% CI 1.9-5.8) for elevated factors VIII, IX, and XI, respectively. Furthermore, our study demonstrates for the first time that elevated factor XII is associated with an increased risk of VTE (adjusted odds ratio 2.9, 95% CI 1.6-5.3).
凝血因子升高已被证明是静脉血栓栓塞症(VTE)的一个危险因素。我们研究的目的是调查年龄、性别、体重指数和口服避孕药对凝血因子VIII、IX、XI和XII活性的影响,以及它们对与凝血因子升高相关的VTE临界值定义和风险的影响。在499名献血者和286名VTE患者中测量了凝血因子VIII、IX、XI和XII的活性。年龄和体重指数显著且独立地预测了凝血因子VIII、IX和XI的活性,而口服避孕药的使用则预测了凝血因子IX、XI和XII的水平。常用于定义凝血因子升高临界值的凝血因子活性百分位数,因年龄、体重指数和口服避孕药的影响而有所不同。凝血因子VIII、IX和XI升高时,VTE的校正比值比分别为10.3[95%置信区间(CI)5.1 - 20.7]、6.1(95%CI 3.1 - 12.0)和3.3(95%CI 1.9 - 5.8)。此外,我们的研究首次表明,凝血因子XII升高与VTE风险增加相关(校正比值比2.9,95%CI 1.6 - 5.3)。